Klow vs Wolverine — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Klow is a vendor peptide blend combining TB-500, BPC-157, KPV, and GHK-Cu - four compounds covering systemic tissue repair, angiogenesis, gut protection, anti-inflammation, and skin regeneration. It is the expanded version of Tri-Heal (TB-500 + BPC-157 + KPV), with GHK-Cu added f...
Calculate Klow dose →Wolverine is a research peptide blend combining BPC-157 (5 mg) and TB-500 (5 mg) in a single vial. BPC-157 drives localized tissue repair and gut protection via angiogenesis; TB-500 promotes systemic cell migration and actin remodeling. Together they target overlapping healing pa...
Calculate Wolverine dose →| Parameter | Klow | Wolverine |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Vendor Blend | Research Blend |
| Half-Life | - | BPC-157: 4-6 h; TB-500: ~5 days |
| Typical Dose | - | 500-1,000 µg |
| Frequency | - | 2-3x per week |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.